BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31021670)

  • 1. The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation.
    Mediouni S; Kessing CF; Jablonski JA; Thenin-Houssier S; Clementz M; Kovach MD; Mousseau G; de Vera IMS; Li C; Kojetin DJ; Evans DT; Valente ST
    FASEB J; 2019 Jul; 33(7):8280-8293. PubMed ID: 31021670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.
    Mediouni S; Chinthalapudi K; Ekka MK; Usui I; Jablonski JA; Clementz MA; Mousseau G; Nowak J; Macherla VR; Beverage JN; Esquenazi E; Baran P; de Vera IMS; Kojetin D; Loret EP; Nettles K; Maiti S; Izard T; Valente ST
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.
    Kessing CF; Nixon CC; Li C; Tsai P; Takata H; Mousseau G; Ho PT; Honeycutt JB; Fallahi M; Trautmann L; Garcia JV; Valente ST
    Cell Rep; 2017 Oct; 21(3):600-611. PubMed ID: 29045830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
    Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A.
    Rice AP
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations.
    Kleinman AJ; Sivanandham S; Sette P; Sivanandham R; Policicchio BB; Xu C; Penn E; Brocca-Cofano E; Le Hingrat Q; Ma D; Pandrea I; Apetrei C
    J Virol; 2022 Jun; 96(12):e0044522. PubMed ID: 35638831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
    Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
    J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat.
    Li C; Mousseau G; Valente ST
    Epigenetics Chromatin; 2019 Apr; 12(1):23. PubMed ID: 30992052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.
    Cartwright EK; Palesch D; Mavigner M; Paiardini M; Chahroudi A; Silvestri G
    J Virol; 2016 Aug; 90(15):6699-6708. PubMed ID: 27170752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.
    Li C; Mori L; Valente ST
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):46-53. PubMed ID: 33586776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.
    Sugimoto C; Tadakuma K; Otani I; Moritoyo T; Akari H; Ono F; Yoshikawa Y; Sata T; Izumo S; Mori K
    J Virol; 2003 Apr; 77(7):4169-80. PubMed ID: 12634375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
    Fennessey CM; Pinkevych M; Immonen TT; Reynaldi A; Venturi V; Nadella P; Reid C; Newman L; Lipkey L; Oswald K; Bosche WJ; Trivett MT; Ohlen C; Ott DE; Estes JD; Del Prete GQ; Lifson JD; Davenport MP; Keele BF
    PLoS Pathog; 2017 May; 13(5):e1006359. PubMed ID: 28472156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct host cell proteins incorporated by SIV replicating in CD4+ T cells from natural disease resistant versus non-natural disease susceptible hosts.
    Stephenson ST; Bostik P; Song B; Rajan D; Bhimani S; Rehulka P; Mayne AE; Ansari AA
    Retrovirology; 2010 Dec; 7():107. PubMed ID: 21162735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.